Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?
30/6 14:30
VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold....
|
|
|
30/6 14:30
VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to hold....